vs

Side-by-side financial comparison of Mind Medicine (MindMed) Inc. (DFTX) and SAFE & GREEN HOLDINGS CORP. (OLOX). Click either name above to swap in a different company.

SAFE & GREEN HOLDINGS CORP. is the larger business by last-quarter revenue ($1.8M vs $906.0K, roughly 1.9× Mind Medicine (MindMed) Inc.). SAFE & GREEN HOLDINGS CORP. runs the higher net margin — -212.0% vs -2634.0%, a 2422.0% gap on every dollar of revenue. On growth, Mind Medicine (MindMed) Inc. posted the faster year-over-year revenue change (-16.1% vs -55.8%).

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.

Safe Auto Insurance Company is an American property and casualty auto insurance carrier. It is a privately held carrier and provider of state-minimum private-passenger auto insurance for drivers in the nonstandard insurance market in 20 states across the US, including Oregon, Ohio, Indiana, Kentucky, Georgia, Pennsylvania, South Carolina, Tennessee, Louisiana, Mississippi, Illinois, Missouri, Arizona, Oklahoma, Kansas, Virginia, Texas, California, Alabama, and Colorado.

DFTX vs OLOX — Head-to-Head

Bigger by revenue
OLOX
OLOX
1.9× larger
OLOX
$1.8M
$906.0K
DFTX
Growing faster (revenue YoY)
DFTX
DFTX
+39.7% gap
DFTX
-16.1%
-55.8%
OLOX
Higher net margin
OLOX
OLOX
2422.0% more per $
OLOX
-212.0%
-2634.0%
DFTX

Income Statement — Q4 FY2023 vs Q3 FY2024

Metric
DFTX
DFTX
OLOX
OLOX
Revenue
$906.0K
$1.8M
Net Profit
$-23.9M
$-3.7M
Gross Margin
-7.2%
Operating Margin
-2450.8%
-127.8%
Net Margin
-2634.0%
-212.0%
Revenue YoY
-16.1%
-55.8%
Net Profit YoY
-386.7%
-3.0%
EPS (diluted)
$-0.58
$-113.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DFTX
DFTX
OLOX
OLOX
Q3 24
$1.8M
Q2 24
$1.3M
Q4 23
$906.0K
$2.0M
Q3 23
$1.2M
$4.0M
Q2 23
$1.3M
$5.1M
Q1 23
$1.3M
$5.5M
Q4 22
$1.1M
$4.1M
Q3 22
$360.0K
$4.1M
Net Profit
DFTX
DFTX
OLOX
OLOX
Q3 24
$-3.7M
Q2 24
$-4.7M
Q4 23
$-23.9M
$-13.6M
Q3 23
$-17.9M
$-3.6M
Q2 23
$-29.1M
$-5.6M
Q1 23
$-24.8M
$-3.5M
Q4 22
$-4.9M
$-3.7M
Q3 22
$-16.5M
$-2.5M
Gross Margin
DFTX
DFTX
OLOX
OLOX
Q3 24
-7.2%
Q2 24
9.3%
Q4 23
-101.4%
Q3 23
-13.5%
Q2 23
0.7%
Q1 23
-1.3%
Q4 22
3.9%
Q3 22
-4.0%
Operating Margin
DFTX
DFTX
OLOX
OLOX
Q3 24
-127.8%
Q2 24
-150.9%
Q4 23
-2450.8%
-536.0%
Q3 23
-1858.6%
-60.3%
Q2 23
-2226.1%
-110.1%
Q1 23
-1624.8%
-59.2%
Q4 22
-1287.0%
-93.0%
Q3 22
-4717.5%
-60.6%
Net Margin
DFTX
DFTX
OLOX
OLOX
Q3 24
-212.0%
Q2 24
-373.1%
Q4 23
-2634.0%
-695.0%
Q3 23
-1541.1%
-91.0%
Q2 23
-2222.0%
-109.0%
Q1 23
-1932.6%
-63.9%
Q4 22
-454.0%
-91.0%
Q3 22
-4579.2%
-59.4%
EPS (diluted)
DFTX
DFTX
OLOX
OLOX
Q3 24
$-113.82
Q2 24
$-3.31
Q4 23
$-0.58
$-21.35
Q3 23
$-0.45
$-0.22
Q2 23
$-0.76
$-7.46
Q1 23
$-0.65
$-5.00
Q4 22
$-0.02
$-12.13
Q3 22
$-0.56
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DFTX
DFTX
OLOX
OLOX
Cash + ST InvestmentsLiquidity on hand
$99.7M
$257.0K
Total DebtLower is stronger
$6.6M
Stockholders' EquityBook value
$78.1M
$-8.2M
Total Assets
$124.5M
$9.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DFTX
DFTX
OLOX
OLOX
Q3 24
$257.0K
Q2 24
$1.0M
Q4 23
$99.7M
$14.2K
Q3 23
$117.7M
$712.9K
Q2 23
$116.9M
$1.6M
Q1 23
$129.4M
$1.5M
Q4 22
$142.1M
$582.8K
Q3 22
$154.5M
$2.1M
Total Debt
DFTX
DFTX
OLOX
OLOX
Q3 24
$6.6M
Q2 24
$12.6M
Q4 23
$4.1M
Q3 23
Q2 23
Q1 23
Q4 22
$3.4M
Q3 22
Stockholders' Equity
DFTX
DFTX
OLOX
OLOX
Q3 24
$-8.2M
Q2 24
$-5.7M
Q4 23
$78.1M
$-7.5M
Q3 23
$96.0M
$5.5M
Q2 23
$106.0M
$9.8M
Q1 23
$130.3M
$12.8M
Q4 22
$150.9M
$14.8M
Q3 22
$153.6M
$17.6M
Total Assets
DFTX
DFTX
OLOX
OLOX
Q3 24
$9.8M
Q2 24
$20.9M
Q4 23
$124.5M
$17.2M
Q3 23
$141.6M
$25.3M
Q2 23
$142.1M
$27.9M
Q1 23
$155.5M
$28.4M
Q4 22
$170.0M
$26.6M
Q3 22
$180.9M
$29.0M
Debt / Equity
DFTX
DFTX
OLOX
OLOX
Q3 24
Q2 24
Q4 23
Q3 23
Q2 23
Q1 23
Q4 22
0.23×
Q3 22

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DFTX
DFTX
OLOX
OLOX
Operating Cash FlowLast quarter
$-20.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DFTX
DFTX
OLOX
OLOX
Q3 24
Q2 24
$-3.7M
Q4 23
$-20.6M
$-2.5M
Q3 23
$-16.6M
$-1.6M
Q2 23
$-13.8M
$-1.7M
Q1 23
$-13.3M
$-1.4M
Q4 22
$-12.8M
$-77.5K
Q3 22
$-9.3M
$-190.6K
Free Cash Flow
DFTX
DFTX
OLOX
OLOX
Q3 24
Q2 24
$-3.7M
Q4 23
$-2.5M
Q3 23
$-1.6M
Q2 23
$-1.7M
Q1 23
$-1.9M
Q4 22
$-841.3K
Q3 22
$-434.8K
FCF Margin
DFTX
DFTX
OLOX
OLOX
Q3 24
Q2 24
-296.7%
Q4 23
-130.2%
Q3 23
-41.3%
Q2 23
-32.7%
Q1 23
-34.7%
Q4 22
-20.5%
Q3 22
-10.5%
Capex Intensity
DFTX
DFTX
OLOX
OLOX
Q3 24
0.0%
Q2 24
2.0%
Q4 23
4.0%
Q3 23
0.1%
Q2 23
0.1%
Q1 23
9.6%
Q4 22
18.6%
Q3 22
5.9%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons